Epstein Secrets

d to provide you with a copy of the confidential Private Placement Memorandum upon request. EFTA00365543 Don Spongberg Senior Managing Director Spencer Trask Ventures Member FINRA & SIPC INVESTMENTS IN THIS OFFERING SHALL BE RESTRICTED SOLELY TO ACCREDITED INVESTORS THAT HAVE BEEN VERIFIED BY THE COMPANY AND THE

o time (the -PPM"). the disclosure in the PPM shall control. Click here to manage your email subscriptions. View the online version of this email. Spencer Trask Ventures. Inc. Member F/NRA & SIPC 1140 Avenue of the Americas. 9th Floor. New York. NY 10036 1700 East Putnam Avenue. Suite 302. Old Greenwich. CT 06870

[email protected]> Subject: Fwd: Vesselon Overview Documents Date: Mon, 11 Aug 2014 11:49:42 +0000 Sent from my iPhone Begin forwarded message: From: "Don Spongberg" < Date: August 8, 2014, 12:03:45 PM EDT To: Subject: Vesselon Overview Documents Reply-To: "Don Spongberg" Dear Jeffrey, I am pleased to presen

re information about this opportunity with Vesselon or any of our other portfolio companies. Best Regards, Don Spongberg Senior Managing Director Spencer Trask Ventures, Inc. Member FINR4 & SIPC 1700 E Putnam Ave, Old Greenwich, CT 06870 Phone: dspongberg&pe ncertrask.com Frequently Asked Questions and Answers:

From: "Don Spongberg" To:' • Subject: Vesselon Approved for Connecticut Angel Investor Tax Credit Date: Tue, 23 Dec 2014 21:50:44 +0000 If you have trouble viewing

s the White Paper. Please call to learn more about how you can help Vesselon reach its goals. Sincerely, Don Spongberg Senior Managing Director Spencer Trask Ventures, Inc. Member FINR4 & SIPC 1700 E Putnam Ave, Old Greenwich, CT 06870 Phone: Download White Paper Now! The Need and Future Market for Noninvasi

From: "Don Spongberg" To:' ' < Subject: Vesselon Recent White Paper - The Need and Future Market for Noninvasive Early Stroke Therapeutics in the Urgent Setting Date: